Payer-Imposed Quantity Limits for Antiemetics: Everybody Hurts
JCO Oncol Pract
.
2022 May;18(5):313-317.
doi: 10.1200/OP.21.00500.
Epub 2021 Nov 22.
Authors
Waqas Haque
1
,
Ramy Sedhom
2
3
,
Fumiko Chino
4
,
Trevor J Royce
5
6
,
Arjun Gupta
7
Affiliations
1
Department of Internal Medicine, New York University Langone Health, New York, NY.
2
Division of Hematology and Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
3
Penn Center for Cancer Care Innovation, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.
4
Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY.
5
Department of Radiation Oncology, University of North Carolina School of Medicine, Chapel Hill, NC.
6
Flatiron Health, New York, NY.
7
Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN.
PMID:
34807740
DOI:
10.1200/OP.21.00500
No abstract available
Publication types
Editorial
Research Support, Non-U.S. Gov't
MeSH terms
Antiemetics*
Humans
Substances
Antiemetics